BYSI - BeyondSpring Inc.
1.51
0.040 2.649%
Share volume: 21,643
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$1.47
0.04
0.03%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-12-2025 | 08-13-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 2.610 M | 1.949 M | 1.790 M | |
| Selling general and admin | 1.736 M | 947.000 K | 751.000 K | |
| Research and development | 874.000 K | 1.002 M | 1.039 M | |
| Total expenses | 2.610 M | 1.949 M | 1.790 M | |
| -25.33% | -8.16% | |||
| Operating income | -2.610 M | -1.949 M | -1.790 M | |
| Ebit | -2.581 M | -1.884 M | -1.736 M | |
| Pretax income | -2.564 M | -1.856 M | -1.717 M | |
| -27.61% | -7.49% | |||
| Income tax | 20.000 K | 22.000 K | 26.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | 1.170 M | -4.649 M | -4.944 M | |
| -497.35% | -6.35% |